BlackRock’s HI-TECH PHARMACAL INC HITK Stock Holding History

BlackRock’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-291	Closed	-$13K	–	3322
2014 Q1	$13K	Hold	291	–	–	﹤0.01%	2592
2013 Q4	$13K	Sell	291 -62	-18%	-$2.68K	﹤0.01%	2595
2013 Q3	$15K	Buy	353 +74	+27%	+$2.83K	﹤0.01%	2432
2013 Q2	$9K	Buy	+279	New	+$9.29K	﹤0.01%	2740

BlackRock's HITK Position: Q2 2014 in Review

BlackRock sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 291 shares — an estimated $13K sold.

BlackRock first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $15K in Q3 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

BlackRock reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
BlackRock sold 291 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $13K.
BlackRock first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
BlackRock's HI-TECH PHARMACAL INC position peaked at $15K in Q3 2013.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on BlackRock's 13F filing for Q2 2014, filed 6 Aug 2014.